Prenetics Global Ltd announced the appointment of Kathryn Henry and David Vanderveen as independent directors on June 13 and June 16, 2024, respectively, to support its shift into consumer health. The filing also clarifies previously registered shares totaling 25,332,509 Class A ordinary shares.